长效药物递送技术及服务市场－全球产业规模、份额、趋势、机会及预测，依技术、剂型、所用材料、通路、地区及竞争格局划分，2020-2030年预测

2024年全球长效药物递送技术与服务市场规模为107.8亿美元，预计2030年将以11.10%的复合年增长率成长至202.7亿美元。长效药物递送技术和服务涵盖旨在延长药物释放时间的系统，从而减少给药频率并提高患者依从性。推动市场扩张的主要因素包括：慢性疾病盛行率的不断上升，使得患者需要持续用药才能达到最佳治疗效果；以及患者对更便捷用药方式（尤其是注射或植入剂）的需求日益增长。此外，维持稳定的药物浓度，从而最大限度地减少峰谷效应，也是推动这些创新递送解决方案发展的重要因素。

主要市场驱动因素

全球慢性病负担日益加重，显着影响了对长效药物传递技术和服务的需求，因为这些疾病需要长期持续的治疗管理。糖尿病、心血管疾病和各种神经系统疾病等都需要维持稳定的药物浓度，以预防併发症并改善患者预后。

主要市场挑战

新型长效製剂研发所需的大量资金投入，对全球长效药物递送技术和服务市场的成长构成了显着阻碍。这项挑战直接导致创新产品上市前需要投入大量资金，并延长研发週期。

主要市场趋势

生物製剂长效製剂日益受到重视，这代表了药物递送市场的一大趋势，其驱动力在于治疗分子的复杂性不断增加。这些製剂能够延长生物製剂的半衰期，从而减少注射次数，这对于提高患者的舒适度和依从性至关重要，尤其对于慢性病患者而言。

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：顾客之声

第五章：全球长效药物递送技术与服务市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依技术分类（注射剂、水凝胶、植入物、微针、奈米晶体悬浮液）
  • 依剂型分类（长效注射剂、长效植入剂、外用/透皮製剂、阴道製剂、其他）
  • 依所用材料分类（聚合物基、非聚合物基）
  • 按分销管道（医院和零售药局、研究和学术机构、其他）
  • 按地区
  • 按公司（2024 年）
• 市场地图

第六章：北美长效药物递送技术与服务市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲长效药物递送技术与服务市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区长效药物递送技术及服务市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东及非洲长效药物递送技术及服务市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿联酋
  • 南非

第十章：南美洲长效药物递送技术与服务市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章：市场动态

• 司机
• 挑战

第十二章：市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章：全球长效药物递送技术与服务市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商议价能力
• 顾客的力量
• 替代产品的威胁

第十五章：竞争格局

• Adare Pharma Solutions
• Alkermes plc
• Camurus AB
• Corium, LLC.
• Creative Biolabs, Inc.
• Delpor, Inc.
• Durect Corporation
• Hanmi Pharm.Co.,Ltd.
• Integrated Bio Systems, Inc.
• Heron Therapeutics, Inc.

第十六章：策略建议

第17章调查会社について・免责事项

The Global Long-Acting Drug Delivery Technologies and Services Market, valued at USD 10.78 Billion in 2024, is projected to experience a CAGR of 11.10% to reach USD 20.27 Billion by 2030. Long-acting drug delivery technologies and services encompass systems designed to release therapeutic agents over extended periods, reducing dosing frequency and improving patient adherence. Primary drivers supporting market expansion include the increasing prevalence of chronic diseases necessitating sustained medication for optimal management and the growing demand for enhanced patient convenience, especially for injectable or implantable formulations. The inherent benefit of maintaining consistent drug levels, thereby minimizing peak-and-trough effects, also represents a fundamental driver for these innovative delivery solutions.

Key Market Drivers

The rising global burden of chronic diseases significantly influences the demand for long-acting drug delivery technologies and services, as these conditions necessitate sustained therapeutic management over extended periods. Diseases such as diabetes, cardiovascular disease, and various neurological disorders require consistent medication levels to prevent complications and improve patient outcomes.

Key Market Challenges

The significant financial investment associated with research and development (R&D) for novel long-acting formulations presents a notable impediment to the growth of the Global Long-Acting Drug Delivery Technologies and Services Market. This challenge directly results in substantial capital requirements and prolonged timelines before innovative products can achieve market entry. The complexity of developing formulations that ensure sustained release and stability over extended periods necessitates extensive preclinical and clinical testing, further escalating costs and extending development cycles.

Key Market Trends

The growing emphasis on biologic-based long-acting formulations represents a significant trend in the drug delivery market, driven by the increasing complexity of therapeutic molecules. These formulations extend the half-life of biologics, thereby reducing the frequency of injections which is crucial for patient comfort and adherence, especially for chronic conditions. Biologics, including monoclonal antibodies and protein-based therapies, often require complex manufacturing and administration regimens, making long-acting versions highly advantageous.

Key Market Players

• Adare Pharma Solutions
• Alkermes plc
• Camurus AB
• Corium, LLC.
• Creative Biolabs, Inc.
• Delpor, Inc.
• Durect Corporation
• Hanmi Pharm.Co.,Ltd.
• Integrated Bio Systems, Inc.
• Heron Therapeutics, Inc.

Report Scope:

In this report, the Global Long-Acting Drug Delivery Technologies and Services Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Long-Acting Drug Delivery Technologies and Services Market, By Technique:

• Injectables
• Hydrogels
• Implants
• Microneedles
• NanocrystalSuspensions

Long-Acting Drug Delivery Technologies and Services Market, By Dosage Forms:

• Long-acting Injectables
• Long-acting Implantable
• Topical / Transdermal
• Vaginal
• Other

Long-Acting Drug Delivery Technologies and Services Market, By Material Used:

• Polymer based
• Non-polymer based

Long-Acting Drug Delivery Technologies and Services Market, By Distribution Channels:

• Hospitals and Retail Pharmacies
• Research and Academics
• Others

Long-Acting Drug Delivery Technologies and Services Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Long-Acting Drug Delivery Technologies and Services Market.

Available Customizations:

Global Long-Acting Drug Delivery Technologies and Services Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Long-Acting Drug Delivery Technologies and Services Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Technique (Injectables, Hydrogels, Implants, Microneedles, NanocrystalSuspensions)
  • 5.2.2. By Dosage Forms (Long-acting Injectables, Long-acting Implantable, Topical / Transdermal, Vaginal, Other)
  • 5.2.3. By Material Used (Polymer based, Non-polymer based)
  • 5.2.4. By Distribution Channels (Hospitals and Retail Pharmacies, Research and Academics, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America Long-Acting Drug Delivery Technologies and Services Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Technique
  • 6.2.2. By Dosage Forms
  • 6.2.3. By Material Used
  • 6.2.4. By Distribution Channels
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Long-Acting Drug Delivery Technologies and Services Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Technique
      • 6.3.1.2.2. By Dosage Forms
      • 6.3.1.2.3. By Material Used
      • 6.3.1.2.4. By Distribution Channels
  • 6.3.2. Canada Long-Acting Drug Delivery Technologies and Services Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Technique
      • 6.3.2.2.2. By Dosage Forms
      • 6.3.2.2.3. By Material Used
      • 6.3.2.2.4. By Distribution Channels
  • 6.3.3. Mexico Long-Acting Drug Delivery Technologies and Services Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Technique
      • 6.3.3.2.2. By Dosage Forms
      • 6.3.3.2.3. By Material Used
      • 6.3.3.2.4. By Distribution Channels

7. Europe Long-Acting Drug Delivery Technologies and Services Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Technique
  • 7.2.2. By Dosage Forms
  • 7.2.3. By Material Used
  • 7.2.4. By Distribution Channels
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Long-Acting Drug Delivery Technologies and Services Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Technique
      • 7.3.1.2.2. By Dosage Forms
      • 7.3.1.2.3. By Material Used
      • 7.3.1.2.4. By Distribution Channels
  • 7.3.2. France Long-Acting Drug Delivery Technologies and Services Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Technique
      • 7.3.2.2.2. By Dosage Forms
      • 7.3.2.2.3. By Material Used
      • 7.3.2.2.4. By Distribution Channels
  • 7.3.3. United Kingdom Long-Acting Drug Delivery Technologies and Services Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Technique
      • 7.3.3.2.2. By Dosage Forms
      • 7.3.3.2.3. By Material Used
      • 7.3.3.2.4. By Distribution Channels
  • 7.3.4. Italy Long-Acting Drug Delivery Technologies and Services Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Technique
      • 7.3.4.2.2. By Dosage Forms
      • 7.3.4.2.3. By Material Used
      • 7.3.4.2.4. By Distribution Channels
  • 7.3.5. Spain Long-Acting Drug Delivery Technologies and Services Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Technique
      • 7.3.5.2.2. By Dosage Forms
      • 7.3.5.2.3. By Material Used
      • 7.3.5.2.4. By Distribution Channels

8. Asia Pacific Long-Acting Drug Delivery Technologies and Services Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Technique
  • 8.2.2. By Dosage Forms
  • 8.2.3. By Material Used
  • 8.2.4. By Distribution Channels
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Long-Acting Drug Delivery Technologies and Services Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Technique
      • 8.3.1.2.2. By Dosage Forms
      • 8.3.1.2.3. By Material Used
      • 8.3.1.2.4. By Distribution Channels
  • 8.3.2. India Long-Acting Drug Delivery Technologies and Services Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Technique
      • 8.3.2.2.2. By Dosage Forms
      • 8.3.2.2.3. By Material Used
      • 8.3.2.2.4. By Distribution Channels
  • 8.3.3. Japan Long-Acting Drug Delivery Technologies and Services Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Technique
      • 8.3.3.2.2. By Dosage Forms
      • 8.3.3.2.3. By Material Used
      • 8.3.3.2.4. By Distribution Channels
  • 8.3.4. South Korea Long-Acting Drug Delivery Technologies and Services Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Technique
      • 8.3.4.2.2. By Dosage Forms
      • 8.3.4.2.3. By Material Used
      • 8.3.4.2.4. By Distribution Channels
  • 8.3.5. Australia Long-Acting Drug Delivery Technologies and Services Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Technique
      • 8.3.5.2.2. By Dosage Forms
      • 8.3.5.2.3. By Material Used
      • 8.3.5.2.4. By Distribution Channels

9. Middle East & Africa Long-Acting Drug Delivery Technologies and Services Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Technique
  • 9.2.2. By Dosage Forms
  • 9.2.3. By Material Used
  • 9.2.4. By Distribution Channels
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Long-Acting Drug Delivery Technologies and Services Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Technique
      • 9.3.1.2.2. By Dosage Forms
      • 9.3.1.2.3. By Material Used
      • 9.3.1.2.4. By Distribution Channels
  • 9.3.2. UAE Long-Acting Drug Delivery Technologies and Services Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Technique
      • 9.3.2.2.2. By Dosage Forms
      • 9.3.2.2.3. By Material Used
      • 9.3.2.2.4. By Distribution Channels
  • 9.3.3. South Africa Long-Acting Drug Delivery Technologies and Services Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Technique
      • 9.3.3.2.2. By Dosage Forms
      • 9.3.3.2.3. By Material Used
      • 9.3.3.2.4. By Distribution Channels

10. South America Long-Acting Drug Delivery Technologies and Services Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Technique
  • 10.2.2. By Dosage Forms
  • 10.2.3. By Material Used
  • 10.2.4. By Distribution Channels
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Long-Acting Drug Delivery Technologies and Services Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Technique
      • 10.3.1.2.2. By Dosage Forms
      • 10.3.1.2.3. By Material Used
      • 10.3.1.2.4. By Distribution Channels
  • 10.3.2. Colombia Long-Acting Drug Delivery Technologies and Services Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Technique
      • 10.3.2.2.2. By Dosage Forms
      • 10.3.2.2.3. By Material Used
      • 10.3.2.2.4. By Distribution Channels
  • 10.3.3. Argentina Long-Acting Drug Delivery Technologies and Services Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Technique
      • 10.3.3.2.2. By Dosage Forms
      • 10.3.3.2.3. By Material Used
      • 10.3.3.2.4. By Distribution Channels

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Long-Acting Drug Delivery Technologies and Services Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Adare Pharma Solutions
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Alkermes plc
• 15.3. Camurus AB
• 15.4. Corium, LLC.
• 15.5. Creative Biolabs, Inc.
• 15.6. Delpor, Inc.
• 15.7. Durect Corporation
• 15.8. Hanmi Pharm.Co.,Ltd.
• 15.9. Integrated Bio Systems, Inc.
• 15.10. Heron Therapeutics, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer